48 The Era ‘or Error’ of Second Localization Procedures

Publication
Article
Miami Breast Cancer Conference® Abstracts Supplement41st Annual Miami Breast Cancer Conference® - Abstracts
Volume 38
Issue 4
Pages: 56

Background

Clip migration is known to occur after a core needle breast biopsy. Radiofrequency and radar (R) breast localization involves a second localization procedure based on the prior clip placement potentially compounding the migration from the original biopsy site. Fluoroscopic intraoperative neoplasm detection (FIND) obviates the need for a second localization by using intraoperative fluoroscopy to localize the original biopsy clip using direct visualization to choose margins. We hypothesize that intraoperative localization based on the original clip vs a second localization would result in fewer positive margins due to second clip migration.

Methods

A retrospective review was performed of patients with a diagnosis of nonpalpable malignancy between the ages of 18 to 99 years who were admitted to the breast surgery service from September 1, 2016, through August 21, 2023, with the following Current Procedural Terminology codes: 19281-19288, 19301, 19302, 19120, 19125, 19290, 19291, 76000, 76098, 76942, 77001, 77002,77021,77031, and 77032. Results were compared between the patients who underwent R localization vs FIND including age, body mass index, imaging, pathology, margins, operative reports, fluoroscopy radiation dose, and cost of each procedure. The Pythagorean theorem was used to calculate the distance in space between the initial biopsy clip and the R localization device. χ2 was used to calculate the 2-tailed P value between the 2 groups.

Results

Radiofrequency/Radar Chip Migration in mm (From Biopsy Clip)

Radiofrequency/Radar Chip Migration in mm (From Biopsy Clip)

We identified 169 patients: 119 patients localized with FIND and 50 localized with R. Five percent (n = 6) of the patients with FIND and 14% (n = 7) of the patients with R had positive margins (P = .04). The average distance between the R device and biopsy clip in patients with positive margins was 20.1 mm and in those with negative margins was 11.8 mm (P = .04). The Figure demonstrates the variation in RF clip migration.

Conclusions

Although the positive margin rate with R localization is equivalent to needle-localized breast biopsies, this was still significantly greater than the positive margin rate with FIND. The positive margin rate was associated with the distance from the localization device to the initial biopsy clip. Eliminating the second localization decreases preoperative procedures and their associated discomfort, cost, and error involved in localizing the tumor and may result in improved margin positivity rates.

Articles in this issue

38 Influence of Race on Attainment of Textbook Oncologic Outcome Following Modified Radical Mastectomy for Breast Cancer
38 Influence of Race on Attainment of Textbook Oncologic Outcome Following Modified Radical Mastectomy for Breast Cancer
39 The Influence of Reconstruction Type on Outcomes in Women Undergoing Mastectomy With Immediate Reconstruction:  A Nationwide Study
39 The Influence of Reconstruction Type on Outcomes in Women Undergoing Mastectomy With Immediate Reconstruction: A Nationwide Study
40 Ethnic Disparities in Complication Rates and Outcomes  of Nipple-Sparing Mastectomy:  A Comprehensive Analysis
40 Ethnic Disparities in Complication Rates and Outcomes of Nipple-Sparing Mastectomy: A Comprehensive Analysis
41 A Case Series of Sarcomas
41 A Case Series of Sarcomas
42 Transitional Lymphedema: Understanding the Temporal Dynamics Post-Axillary Surgery
42 Transitional Lymphedema: Understanding the Temporal Dynamics Post-Axillary Surgery
43 Impact of Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) on Postoperative Complication Rates in Mastectomy With Immediate Prosthetic-Based Breast Reconstruction
43 Impact of Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) on Postoperative Complication Rates in Mastectomy With Immediate Prosthetic-Based Breast Reconstruction
44 Variant of Uncertain Significance (VUS) Genetic Testing Results and Mastectomy Choice in Lumpectomy-Eligible Patients
44 Variant of Uncertain Significance (VUS) Genetic Testing Results and Mastectomy Choice in Lumpectomy-Eligible Patients
45 Application of the 7-Gene Biosignature in Palpable Versus Nonpalpable Ductal Carcinoma In Situ in a Black Patient Population: Does Palpability Suggest a More Aggressive Genomic Risk?
45 Application of the 7-Gene Biosignature in Palpable Versus Nonpalpable Ductal Carcinoma In Situ in a Black Patient Population: Does Palpability Suggest a More Aggressive Genomic Risk?
46 Comparative Analysis of Breast Conserving Therapy vs Mastectomy in Multifocal and Multicentric Breast Cancer: A Review of the Literature
46 Comparative Analysis of Breast Conserving Therapy vs Mastectomy in Multifocal and Multicentric Breast Cancer: A Review of the Literature
47 Can We Identify Factors That Predict DCIS Upgrade to Invasive Cancer at Mastectomy?
47 Can We Identify Factors That Predict DCIS Upgrade to Invasive Cancer at Mastectomy?
48 The Era ‘or Error’ of Second Localization Procedures
48 The Era ‘or Error’ of Second Localization Procedures
49 The Influence of Race on Complications in Breast Conservation Surgery: A Single Institution Study
49 The Influence of Race on Complications in Breast Conservation Surgery: A Single Institution Study
51 Ductal Carcinoma In Situ With Microinvasion on Biopsy—What Are the Predictors of Upstaging?
51 Ductal Carcinoma In Situ With Microinvasion on Biopsy—What Are the Predictors of Upstaging?
52 UK Experience of Non-Radioisotope, Non-Magnetic Guided Breast Wide Local Excision and Sentinel Node Biopsy
52 UK Experience of Non-Radioisotope, Non-Magnetic Guided Breast Wide Local Excision and Sentinel Node Biopsy
53 The Utility of Sentinel Lymph Node Biopsy in High-Grade Ductal Carcinoma In Situ
53 The Utility of Sentinel Lymph Node Biopsy in High-Grade Ductal Carcinoma In Situ
Related Videos
Pegulicianine-guided breast cancer surgery may allow practices to de-escalate subsequent radiotherapy, says Barbara Smith, MD, PhD.
Barbara Smith, MD, PhD, spoke about the potential use of pegulicianine-guided breast cancer surgery based on reports from the phase 3 INSITE trial.
Carey Anders, MD, an expert on breast cancer
Carey Anders, MD, an expert on breast cancer
Carey Anders, MD, an expert on breast cancer
Related Content